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Abstract. The purpose of this article is to describe the
psychophysiology of dyspnea in chronic obstructive pulmonary
disease (COPD), identify the unique impact of respiratory
disease on the female patient, and discuss the relationship of
anxiety and depression in disease manifestation. Current COPD
assessment and treatment guidelines published by the United
States Department of Health and Human Services, the World
Health Organization as well as the National Institute for Health
and Care Experience (NICE) will be presented along with im-
plications for the Advanced Practice Nurse (APN). Practitioners
treat COPD patients with advanced physiological complications
along with psychological comorbidities that worsen the disease
perception and progression. Therefore, a recommendation will
be made to integrate assessment and evaluation of psychological
comorbidities in COPD patients, with particular consideration
given to the female patient. Utilizing a holistic, int egrated
treatment plan will serve to enhance patient care, alleviate
disease burden and impact overall quality of life in the patient
with COPD.
Keywords chronic obstructive pulmonary disease (COPD), dys-
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1 Introduction
Chronic respiratory diseases, such as chronic obstructive pul-
monary disease (COPD), are the third leading cause of death in
America, behind heart disease and cancer (Centers for Disease
Control and Prevention, United States Department of Health and
Human Services (CDC), 2012). COPD is a term that refers to
a large group of deteriorating respiratory diseases that interfere
with breathing due to airway obstruction (American Lung Asso-
ciation (ALA), 2013a). COPD limits quality of life (QOL) by pre-
venting or limiting every day activities such as working, activities
requiring physical exertion, household chores and participation in
family activities (ALA, 2013a). Consequently, individuals with
COPD frequently report lower than normal health-related QOL,
while also demonstrating increased levels of anxiety and depres-
sion (Arne et al., 2009), along with decreased capacity for exercise,
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decreased physical activity levels and non-completion of self-care
activities of daily living (ADLs) (Pitta et al., 2006). HRQoL en-
compasses the more subjective influence of the disease on the qual-
ity of life and how overall QOL in turn affects personal mental and
physical health (Ketelaars et al., 1996; CDC, 2000). The delete-
rious effects of COPD on QOL can be partially attributed to the
associated sensation of difficulty breathing, or dyspnea (Burgel et
al., 2013). Dyspnea has been rated as one of the most signifi-
cant contributors to diminished HRQoL in patients with COPD
(Nishimura et al., 2008).
This article utilizes available psychophysiological evidence to
provide Advanced Practice Nurses (APNs) an overview of the
need for assessment of psychological comorbidities in patients with
chronic obstructive pulmonary disease (COPD) in order to better
manage patient outcomes and improve quality of life. Further,
this article will describe the role dyspnea plays in perception of
health-related quality of life (HRQoL), the unique psychological
comorbidities often noted in female COPD patients, current prac-
tice guidelines related to COPD care, and implications for the
Advanced Practice Nurse (APN).
2 Dyspnea
To fully examine the effects of dyspnea on the patient, it is first
necessary to understand the neurological processing of negative
(aversive) respiratory sensations. During a COPD exacerbation,
the respiratory system is presented with a ‘load‘ that disrupts
normal bodily homeostasis and must be physically overcome or
adapted to. An example of a respiratory load is an increase
in lower airway resistance, accumulation of mucus, or bronchial
spasms. There are two primary cognitive components to the per-
ception of increased respiratory loads: discriminative and affective
(Davenport & Vovk, 2009). Initially, the brain discriminates the
respiratory sensation through a complex interaction among multi-
ple respiratory afferent groups and brainstem centers that control
respiratory motor drive (Davenport & Vovk, 2009). This is the
somatosensory event related to cognitive awareness of breathing
disruption.
During the following affective phase, the individual qualifies
how he or she feels as a result of the aversive respiratory event
and if the sensation is unpleasant. In experimental settings,
subjects seldom report unpleasant evaluations of short or single
breath loads, but this changes with persistent dyspnea and re-
sults in increases in unpleasant affective evaluation (Alexander-
Miller & Davenport, 2010). Extremely large resistive loads have
been shown to induce fear of suffocation and increased discomfort
(Pappens, Smets, Van den Bergh & Van Diest, 2012b). The na-
ture of this affective phase is highly variable across individuals.
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Females tend to magnify their perception of extended respiratory
loads (Alexander-Miller and Davenport, 2010), while highly anx-
ious subjects have reduced respiratory sensory gating leading to
altered perception (Chan et al., 2012).
Due to the progressive and chronic nature of COPD, patients of-
ten experience sustained, undesirable respiratory sensations that
lead to discomfort and altered perception of their breathing.
These sensations vary by individual, based upon gender, previous
experiences, and levels of anxiety (Alexander-Miller & Davenport,
2010; Chan et al., 2012).
Individuals who report extreme “fear of suffocation” experience
increased physical discomfort associated with dyspnea (Pappens
et al., 2012a). These individuals tend to place greater strain on
respiratory muscles by increasing ventilatory response to loads.
This added physiological strain results in a mutual reinforcement
of both fear and maladaptive breathing (Pappens et al., 2012b).
Some individuals react with extreme fear to respiratory stimula-
tion, such as increased carbon dioxide, which can trigger a hyper-
sensitive fear network (Nardi, Freire & Zin, 2009; Sinha, Papp &
Gorman, 2000). Studies have shown that COPD patients experi-
ence restricted ability to perform ADLs and this fear of dyspnea
leads to avoidance of activities (Janssens et al., 2011; Mikkelsen
et al., 2004; Ng et al., 2007; Yohannes, Baldwin & Connolly, 2000;
Zoeckler et al., 2012; Zoeckler et al., 2014).
Essentially, individuals with chronic respiratory disease learn
to fear disease exacerbations, specifically dyspnea (Janssens et
al., 2011). This fear is self-potentiating and eventually becomes
limiting as individuals avoid activities (such as social events, en-
gaging in physical activity or ADLs, or even leaving their home),
potentially contributing to further social isolation, physical de-
conditioning and reduced QOL (Thomas, Decramer & O’Donnell,
2013).
3 Psychological Comorbidities
Furthering the physiological detrimental effects and morbidity
of chronic respiratory disease is the added burden of psychologi-
cal comorbidities. Depression and anxiety are comorbidities fre-
quently associated with COPD (Kunik et al., 2005), with preva-
lence estimates generally higher than other advanced chronic dis-
eases (Maurer et al., 2008). These psychological comorbidities
associated with COPD are often left untreated or under-treated
(Cully et al., 2006), leading to decreased QOL, increased rates of
hospitalization, and reductions in treatment adherence (Stapleton
et al., 2005).
It is still unclear what the exact relationship direction is be-
tween depression and anxiety in COPD, but a recent study found
that depression adversely affects COPD prognosis, resulting in
increased exacerbation risk and possibly death (Atlantis et al.,
2013). Management of depression and anxiety may improve QOL
while increasing capacity for physical activity and treatment ad-
herence (Stapleton et al., 2005; Light et al., 1985). COPD has
also been shown to contribute to the emergence and exacerba-
tion of psychiatric disorders such as depression and anxiety and
may decrease treatment adherence by diverting cognitive resources
(Turan, Yemez & Itil, 2013).
4 Unique impact on the female
patient
Female COPD mortality has been on a steady rise and has quadru-
pled since 1980 (ALA, 2013b). Since 2000, COPD has claimed
more female than male lives, with women making up 53% of
COPD deaths (CDC, 2012). The impact of COPD on women
in particular is understudied, despite evidence showing gender-
based differences in treatment response (Haave, Skumlien & Hy-
land, 2008; Varkey, 2004).
COPD more adversely affects women than it does men, and
women with COPD have higher levels of anxiety and depression
(Di Marco et al. 2006). The quality of life for women is im-
pacted earlier in life than their male counterparts with similar
disease severity (de Torres et al., 2006; Naberan et al., 2012). This
may be attributed to increases in subjective feelings of shortness
of breath, which has a strong correlation for QOL (van Haren-
Willems & Heijdra, 2010). Women show more variance in reports
of symptom intensity (particularly dyspnea) than males with sim-
ilar disease progression and also have lower exercise capacity (de
Torres et al., 2006). An in-depth 2014 study by Raherison et
al. found significant gender differences impacting the female pa-
tient, particularly from chronic sputum. Females reported lower
QOL than men and were more impacted by chronic cough, despite
lower GOLD-staged disease severity (Raherison et al., 2014). The
Global Initiative for Chronic Obstructive Lung Disease (GOLD)
provides evidence-based guidelines for assessment, diagnosis, man-
agement, diagnostic spirometry and staging criteria of airflow lim-
itation in the severity of COPD (GOLD, 2014).
Women also feel that they experience diagnostic delays, have
trouble reaching their physician, and believe their treatment time
with a physician to be insufficient (Martinez et al., 2012). The
delay in diagnosis for female patients can be credited to COPD
being historically thought of as an “older white man’s disease.”
Although the disease remains undiagnosed in women much longer
than for men, COPD continues to develop rapidly in women and
must be addressed in primary care. The ALA (2013b) called for
“taking action” against rising COPD morbidity and mortality, en-
couraging healthcare providers to adopt practices and policies to
improve diagnosis and screening of COPD in women.
5 Clinical COPD Guidelines
APNs use a process of diagnostic reasoning to assess, evaluate
and recommend treatment for the patient. The four major con-
cepts addressed in all current assessment guidelines are diagnosis,
evaluation, management, and treatment. Together, each category
enhances the other by integrating available patient evidence to fa-
cilitate optimal care by the provider while lessening the chance of
misdiagnosis and biases. Considering the consequences of dyspnea
on QOL and subsequent psychological effects, it is recommended
that an early psychological evaluation including screening for anx-
iety and depression be assimilated into each of the four concepts of
care. Raherison et al. (2014) recommend management of COPD
should incorporate psychological distress and socioeconomic sta-
tus, particularly in women who are unemployed and living alone,
and consider the specific impact of chronic sputum in women.
The National Institute for Health and Care Experience (NICE)
and GOLD have published professional guidelines for COPD
assessment and coexisting comorbidities (NICE, 2014; GOLD,
2014). NICE guideline 91 highlights the importance of early
identification of patients with a chronic health condition, such as
COPD, who are at increased risk for depression and functional im-
pairment (NICE, 2014). The guidelines address disease-associated
mood fluctuations, loss of pleasure in activities, pain, functional
impairment and disability that can increase the risk of depres-
sion and anxiety. Cote and Chapman (2009) report that psychi-
atric disorders such as depression are three times more common
in women with COPD than in men with COPD. Women admit
to these manifestations while reporting their chief complaint to a
provider (Cote & Chapman, 2009). Therefore, assessing for anx-
iety and depression in women with COPD and implementing the
standards set forth in the GOLD and NICE guidelines will en-
hance the quality of care provided by APNs for the female COPD
patient.
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6 Final Commentary
While clinical guidelines are well established to diagnose and
treat COPD, practice guidelines target isolated diseases and do
not encompass comorbidities, presenting a challenge in COPD
care (Garcia-Olmos et al., 2013). Like many chronic diseases,
COPD affects multiple aspects of the patient and varies by each
patient. Vigilant review of clinical practice guidelines is necessary
to optimize evidence-based care. Providers should be alert to the
high risk of psychological comorbidities and screen patients for
depression and anxiety upon initial presentation (Maurer et al.,
2008). Early psychological assessment and intervention can be
accomplished with addition of HRQoL evaluation using the VQ-
11 scale, a short questionnaire completed by the patient, which
provides a reliable COPD-specific HRQoL measure and is recom-
mended for routine practice (Ninot et al., 2013). Early recogni-
tion, supportive care and treatment can ease the burden of psy-
chological comorbidities in patients with COPD.
A holistic, integrated treatment plan will serve to optimize pa-
tient outcomes, decrease the burden of symptoms, prevent/man-
age exacerbations, slow disease progression, reduce disease mor-
bidity and overall improve the HRQoL in the patient with COPD.
In summary, psychological and perceptual assessment should
evolve as a new priority in clinical assessment of COPD patients.
Females with COPD demonstrate increased physical and psycho-
logical burden from their disease, yet there is no specialized treat-
ment plan to address this population. Future research should aim
to quantify the predictors of psychological comorbidities in COPD
patients and develop guidelines to address these factors.
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